Hachulla E, Wechsler B, Deveaux M, Godeau P, Hatron P Y, Devulder B, Janin A, Marchandise X
Service de médecine interne, hôpital Claude-Huriez, CHRU, Lille, France.
Rev Med Interne. 1994 Mar;15(3):182-5. doi: 10.1016/s0248-8663(05)82145-9.
We evaluated the value of serum amyloid P component scintigraphy (123I-SAP) and labial salivary gland biopsy in four patients with apparently localized amyloidosis. One patient had pharyngeal amyloidosis, the second laryngeal amyloidosis, the third retro-ocular amyloidosis and the fourth had carpal tunnel syndrome. Three patients (no 2, no 3, no 4) have abnormal whole body retention of 123I-SAP and positive labial salivary gland biopsy for amyloidosis. Only the first patient had effectively localized amyloidosis and local treatment was sufficient. Melphalan was given to the patients no 2 and no 3, colchicine was given to the patient no 4. Labial salivary gland biopsy and 123I-SAP scintigraphy may give positive argument for the diagnosis of systemic amyloidosis in patients with apparently localized amyloidosis.
我们评估了血清淀粉样蛋白P成分闪烁扫描术(123I-SAP)和唇唾液腺活检在4例明显局限性淀粉样变性患者中的价值。1例患者为咽部淀粉样变性,第2例为喉部淀粉样变性,第3例为眼后淀粉样变性,第4例患有腕管综合征。3例患者(第2、3、4例)123I-SAP全身滞留异常,唇唾液腺活检显示淀粉样变性阳性。仅第1例患者有有效的局限性淀粉样变性,局部治疗就足够了。第2例和第3例患者接受了美法仑治疗,第4例患者接受了秋水仙碱治疗。唇唾液腺活检和123I-SAP闪烁扫描术可为明显局限性淀粉样变性患者的系统性淀粉样变性诊断提供阳性依据。